Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TERT | O14746 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12058576 | 0.97 | CA12 (0.34) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL12058557 | 0.88 | MEN1 (0.36) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL9986058 | 0.87 | CA12 (0.37) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL12058575 | 0.85 | CA12 (0.35) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL18379202 | 0.81 | STAT3 (0.41) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL15108564 | 0.81 | NPSR1 (0.35) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL15810567 | 0.79 | HIF1A (0.42) | STAT3HIF1AMEN1KMT2APOLB | |
| SCHEMBL17190576 | 0.79 | HIF1A (0.42) | STAT3HIF1AMEN1KMT2APOLB | |
| SCHEMBL7485582 | 0.79 | HIF1A (0.42) | STAT3HIF1AMEN1KMT2APOLB | |
| SCHEMBL22015900 | 0.79 | HIF1A (0.42) | STAT3HIF1AMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9290494-B2 | Systems for the light-induced separation of charges | CYNORA GMBH (DE) | 2016-03-22 | — | — | US | disclosed |
| US-20110318842-A1 | SYSTEMS FOR THE LIGHT-INDUCED SEPARATION OF CHARGES | LUDWIG-MAXIMILLIANS-UNIVERSITÄT (DE) | 2011-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110318842-A1 | SYSTEMS FOR THE LIGHT-INDUCED SEPARATION OF CHARGES | CRY2, CYBA, CRY1 | CA12 1629/4885CA1 2667/4885CA2 856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.